Hirect Intrinsic Value
Hirect intrinsic value. Hirect (HIRECT) median intrinsic value is ₹332.82 from 9 valuation models (range ₹294–₹1669), vs current price ₹1109.40 — -70.0% downside (Trading Above Calculated Value), margin of safety -100.0%. Read HIRECT dividend growth for the complete payout history and dividend yield track record.
HIRECT Valuation Methods Summary — DCF, Graham Number & P/E
Hirect intrinsic value across 9 models vs current price ₹1109.40 — upside/downside and value range per method. Compare with HIRECT DCF valuation to assess whether the stock is under or overvalued.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹332.82 | ₹266.26 - ₹399.38 | -70.0% | EPS: ₹6.08, Sector P/E: 12x |
| Book Value Method | asset | ₹294.29 | ₹264.86 - ₹323.72 | -73.5% | Book Value/Share: ₹294.29, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹1284.57 | ₹1156.11 - ₹1413.03 | +15.8% | Revenue/Share: ₹1605.71, P/S: 0.8x |
| EBITDA Multiple Method | earnings | ₹443.76 | ₹399.38 - ₹488.14 | -60.0% | EBITDA: ₹36.00Cr, EV/EBITDA: 6x |
| Simple DCF (5Y) | dcf | ₹1668.81 | ₹1335.05 - ₹2002.57 | +50.4% | CF Growth: 15.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹332.82 | ₹299.54 - ₹366.10 | -70.0% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹332.82 | ₹299.54 - ₹366.10 | -70.0% | Revenue Growth: 6.0%, Adj P/E: 8.2x |
| Graham Defensive Method | conservative | ₹332.82 | ₹299.54 - ₹366.10 | -70.0% | EPS: ₹6.08, BVPS: ₹294.29 |
| Dividend Yield Method | dividend | ₹332.82 | ₹299.54 - ₹366.10 | -70.0% | DPS: ₹1.40, Target Yield: 3.5% |
HIRECT Intrinsic Value vs Market Price — All Valuation Models
Hirect fair value range ₹294–₹1669 vs current market price ₹1109.40 across 9 valuation models. For current market price and key ratios, visit Hirect stock price NSE.
HIRECT Intrinsic Value Analysis — Undervalued or Overvalued?
Hirect median intrinsic value ₹332.82, current price ₹1109.40 — Trading Above Calculated Value by 70.0%, margin of safety -100.0%.
What is the intrinsic value of HIRECT?
Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of Hirect (HIRECT) is ₹332.82 (median value). With the current market price of ₹1109.40, this represents a -70.0% variance from our estimated fair value.
The valuation range spans from ₹294.29 to ₹1668.81, indicating ₹294.29 - ₹1668.81.
Is HIRECT undervalued or overvalued?
Based on our multi-method analysis, Hirect (HIRECT) appears to be trading above calculated value by approximately 70.0%.
HIRECT Financial Health — Key Ratios vs Industry Benchmarks
Hirect financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 7.37 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | -3.9% | Industry Standard: 15%+ | Below 10% | Measures shareholder return efficiency |
| Operating Margin | 3.0% | Industry Standard: 20%+ | Below 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 1.70x | Industry Standard: 1.0x+ | Above 1.0x | Measures asset utilization efficiency |
HIRECT Cash Flow Quality — Operating & Free Cash Flow
Hirect operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2026 | ₹86 Cr | ₹41 Cr | Positive Free Cash Flow | 7/10 |
| March 2025 | ₹36 Cr | ₹24 Cr | Positive Free Cash Flow | 8/10 |
| March 2024 | ₹34 Cr | ₹24 Cr | Positive Free Cash Flow | 8/10 |